Rchr
J-GLOBAL ID：202201002855753425
Update date: Mar. 04, 2026
Fukuoka Shota
フクオカ ショウタ | Fukuoka Shota
Affiliation and department：
Research theme for competitive and other funds (1)：
- 2023 - 2025 Tumor agnostic analysis of intra-tumor microbiota to elucidate immune response
Papers (39)：
-
Nina Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama, Daisuke Motooka, Dieter M. Tourlousse, Yuko Shigeno, Yuki Matsumoto, Hiroyuki Yamano, Kazutoshi Murotomi, Hideyuki Tamaki, et al. Microbiota-driven antitumour immunity mediated by dendritic cell migration. Nature. 2025
-
Ayaka Tsuge, Sho Watanabe, Akihito Kawazoe, Yosuke Togashi, Kota Itahashi, Mari Masuda, Atsuo Sai, Shogo Takei, Hiromi Muraoka, Shuichi Ohkubo, et al. The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment. Cancer immunology research. 2024
-
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Yoshiaki Nakamura, Yasutoshi Kuboki, Daisuke Kotani, Takashi Kojima, et al. Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer. Journal for immunotherapy of cancer. 2024. 12. 2
-
Keitaro Shimozaki, Izuma Nakayama, Daisuke Takahari, Kengo Nagashima, Koichiro Yoshino, Koshiro Fukuda, Shota Fukuoka, Hiroki Osumi, Mariko Ogura, Takeru Wakatsuki, et al. Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study. Journal of Gastric Cancer. 2023. 23. 4. 609-621
-
Hiroki Yukami, Akihito Kawazoe, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Naoki Takahashi, Takashi Kojima, Masako Asayama, Takako Yoshii, et al. Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022. 28. 16. 3480-3488
ｍore...
MISC (33)：
-
Koji Inamori, Yosuke Togashi, Hideaki Bando, Yuichiro Tsukada, Shota Fukuoka, Ayako Suzuki, Yutaka Suzuki, Daisuke Kotani, Motohiro Kojima, Makoto Fukui, et al. Efficacy predictors of preoperative CRT and consolidation nivolumab in patients with locally advanced rectal cancer. ANNALS OF ONCOLOGY. 2021. 32. S343-S343
-
Koji Inamori, Yosuke Togashi, Hideaki Bando, Yuichiro Tsukada, Shota Fukuoka, Ayako Suzuki, Yutaka Suzuki, Daisuke Kotani, Motohiro Kojima, Makoto Fukui, et al. Translational research of VOLTAGE-A: Efficacy predictors of preoperative chemoradiotherapy and consolidation nivolumab in patients with both microsatellite stable and microsatellite instability-high locally advanced rectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
-
福岡聖大, 西川博嘉, 西川博嘉, 西川博嘉. Anti-tumor immune response and gut microbiome. 医学のあゆみ. 2021. 278. 9
-
Satoshi Yuki, Hideaki Bando, Yuichiro Tsukada, Koji Inamori, Yoshito Komatsu, Shigenori Homma, Mamoru Uemura, Takeshi Kato, Daisuke Kotani, Shota Fukuoka, et al. Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
-
Koji Inamori, Yosuke Togashi, Hideaki Bando, Yuichiro Tsukada, Ayako Suzuki, Yutaka Suzuki, Daisuke Kotani, Shota Fukuoka, Motohiro Kojima, Makoto Fukui, et al. Translational research of voltage-A1: Efficacy predictors of preoperative chemoradiotherapy and subsequent nivolumab monotherapy in patients with microsatellite-stable locally advanced rectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
ｍore...
Return to Previous Page
